| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.716 | 0.004 | 0.716 | Superoxide dismutase inhibitor | 0.51 0.012 CID_5288478 | ||
| 0.661 | 0.01 | 0.661 | Thioredoxin glutathione reductase inhibitor | |||
| 0.671 | 0.027 | 0.671 | Caspase 9 stimulant | |||
| 0.584 | 0.004 | 0.584 | Breast cancer-resistant protein inhibitor | |||
| 0.583 | 0.003 | 0.583 | Alcohol oxidase inhibitor | |||
| 0.574 | 0.019 | 0.574 | Streptokinase A inhibitor | |||
| 0.557 | 0.012 | 0.557 | Calcium channel L-type activator | |||
| 0.533 | 0.002 | 0.533 | Triose-phosphate isomerase inhibitor | |||
| 0.534 | 0.005 | 0.534 | Mcl-1 antagonist | |||
| 0.542 | 0.015 | 0.542 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.542 | 0.016 | 0.542 | GABA C receptor rho-3 antagonist | |||
| 0.516 | 0.008 | 0.516 | Sigma receptor agonist | |||
| 0.514 | 0.022 | 0.514 | Aryl hydrocarbon receptor agonist | |||
| 0.511 | 0.029 | 0.511 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.487 | 0.006 | 0.487 | Calcium channel activator | |||
| 0.485 | 0.028 | 0.485 | Calpain 2 inhibitor | |||
| 0.448 | 0.004 | 0.448 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.452 | 0.016 | 0.452 | Vasodilator | 0.336 0.037 CID_5288478 | ||
| 0.47 | 0.035 | 0.47 | Vasodilator, peripheral | |||
| 0.439 | 0.004 | 0.439 | UDP-glucose 4-epimerase inhibitor | |||
| 0.438 | 0.004 | 0.438 | Porphobilinogen synthase inhibitor | |||
| 0.466 | 0.042 | 0.466 | Histamine release inhibitor | 0.225 0.176 CID_5288478 | ||
| 0.433 | 0.011 | 0.433 | Dual specificity phosphatase 3 inhibitor | |||
| 0.418 | 0.008 | 0.418 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.458 | 0.048 | 0.458 | 5 Hydroxytryptamine release inhibitor | |||
| 0.389 | 0.004 | 0.389 | Nitric-oxide synthase stimulant | |||
| 0.412 | 0.031 | 0.412 | Vasodilator, coronary | |||
| 0.392 | 0.015 | 0.392 | Dual specificity phosphatase inhibitor | |||
| 0.379 | 0.004 | 0.379 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.227 0.012 CID_5288478 | ||
| 0.377 | 0.003 | 0.377 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.39 | 0.022 | 0.485 | Peroxidase inhibitor | 0.485 0.011 CID_5288478 | CID_5288478 | |
| 0.368 | 0.005 | 0.368 | Interleukin 4 antagonist | |||
| 0.366 | 0.006 | 0.366 | GABA C receptor agonist | |||
| 0.404 | 0.045 | 0.404 | 5 Hydroxytryptamine release stimulant | |||
| 0.36 | 0.014 | 0.36 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.379 | 0.033 | 0.379 | DNA damaging | |||
| 0.349 | 0.005 | 0.349 | Adenylate kinase inhibitor | 0.178 0.019 CID_5288478 | ||
| 0.35 | 0.005 | 0.35 | Succinate dehydrogenase inhibitor | |||
| 0.344 | 0.005 | 0.466 | Histidine decarboxylase inhibitor | 0.466 0.003 CID_5288478 | CID_5288478 | |
| 0.332 | 0.006 | 0.332 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.336 | 0.014 | 0.336 | Amylase inhibitor | |||
| 0.336 | 0.015 | 0.336 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.372 | 0.051 | 0.372 | Aldehyde oxidase inhibitor | |||
| 0.395 | 0.079 | 0.395 | Antibacterial | 0.345 0.105 CID_5288478 | ||
| 0.416 | 0.103 | 0.416 | Transcription factor inhibitor | |||
| 0.328 | 0.016 | 0.328 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.333 | 0.027 | 0.333 | Anesthetic general | |||
| 0.335 | 0.03 | 0.335 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.413 | 0.109 | 0.413 | Alpha-glucosidase inhibitor | |||
| 0.314 | 0.011 | 0.314 | Toll-Like receptor 9 antagonist | |||
| 0.308 | 0.007 | 0.308 | Ferrochelatase inhibitor | |||
| 0.303 | 0.003 | 0.303 | Thioredoxin reductase inhibitor | |||
| 0.408 | 0.11 | 0.408 | Apoptosis agonist | 0.237 0.229 CID_5288478 | ||
| 0.298 | 0.003 | 0.298 | Thioredoxin inhibitor | 0.123 0.029 CID_5288478 | ||
| 0.35 | 0.057 | 0.35 | 12-Lipoxygenase inhibitor | |||
| 0.291 | 0.004 | 0.291 | Potassium channel large-conductance Ca-activated activator | |||
| 0.288 | 0.003 | 0.288 | Biliverdin reductase inhibitor | |||
| 0.296 | 0.015 | 0.296 | Interleukin 6 antagonist | 0.17 0.064 CID_5288478 | ||
| 0.398 | 0.12 | 0.398 | DNA polymerase beta inhibitor | |||
| 0.295 | 0.019 | 0.295 | NOS3 expression enhancer | |||
| 0.295 | 0.02 | 0.295 | Cytidine deaminase inhibitor | |||
| 0.303 | 0.031 | 0.303 | RNA-directed DNA polymerase inhibitor | |||
| 0.287 | 0.017 | 0.287 | Heat shock protein 90 alpha antagonist | |||
| 0.273 | 0.005 | 0.273 | Creatine kinase inhibitor | |||
| 0.31 | 0.043 | 0.31 | Interleukin agonist | 0.24 0.086 CID_5288478 | ||
| 0.313 | 0.047 | 0.313 | Transcription factor STAT3 inhibitor | 0.187 0.154 CID_5288478 | ||
| 0.268 | 0.005 | 0.268 | CF transmembrane conductance regulator agonist | |||
| 0.384 | 0.122 | 0.384 | DNA directed DNA polymerase inhibitor | |||
| 0.345 | 0.084 | 0.345 | Prostaglandin dehydrogenase inhibitor | |||
| 0.275 | 0.016 | 0.275 | NADPH oxidase inhibitor | |||
| 0.308 | 0.051 | 0.308 | Transcription factor STAT inhibitor | |||
| 0.287 | 0.031 | 0.287 | DNA methyltransferase I inhibitor | 0.151 0.103 CID_5288478 | ||
| 0.259 | 0.007 | 0.259 | Calcium antagonist | |||
| 0.271 | 0.019 | 0.271 | Histone acetyltransferase inhibitor | |||
| 0.29 | 0.04 | 0.29 | Gastrin inhibitor | 0.257 0.071 CID_5288478 | ||
| 0.257 | 0.007 | 0.257 | Potassium channel (Ca-activated) activator | |||
| 0.258 | 0.008 | 0.258 | Carbonic anhydrase III inhibitor | |||
| 0.294 | 0.046 | 0.294 | DNA synthesis inhibitor | |||
| 0.29 | 0.046 | 0.29 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.283 | 0.039 | 0.283 | Calpain inhibitor | 0.188 0.125 CID_5288478 | ||
| 0.257 | 0.014 | 0.257 | Glutamate receptor antagonist | |||
| 0.248 | 0.006 | 0.248 | Phosphodiesterase 7B inhibitor | |||
| 0.244 | 0.005 | 0.244 | Interleukin 5 antagonist | |||
| 0.255 | 0.017 | 0.255 | Aldehyde dehydrogenase inhibitor | |||
| 0.273 | 0.037 | 0.303 | Peptidyltransferase inhibitor | 0.303 0.024 CID_5288478 | CID_5288478 | |
| 0.236 | 0.002 | 0.236 | Catechol O-methyltransferase inhibitor | |||
| 0.247 | 0.014 | 0.247 | Cathepsin H inhibitor | |||
| 0.249 | 0.017 | 0.249 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.236 | 0.004 | 0.236 | DOPA decarboxylase inhibitor | |||
| 0.245 | 0.013 | 0.461 | Aminopeptidase B inhibitor | 0.461 0.003 CID_5288478 | CID_5288478 | |
| 0.245 | 0.017 | 0.245 | Alkylator | 0.142 0.051 CID_5288478 | ||
| 0.241 | 0.018 | 0.241 | Cell wall synthesis inhibitor | 0.208 0.027 CID_5288478 | ||
| 0.262 | 0.042 | 0.262 | DNA methylase inhibitor | 0.24 0.054 CID_5288478 | ||
| 0.225 | 0.005 | 0.225 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.226 | 0.009 | 0.226 | Phosphofructokinase-1 inhibitor | |||
| 0.236 | 0.02 | 0.236 | Hexokinase inhibitor | |||
| 0.27 | 0.056 | 0.27 | Pyruvate kinase inhibitor | |||
| 0.221 | 0.008 | 0.221 | Urease inhibitor | |||
| 0.235 | 0.023 | 0.235 | Alkaline phosphatase inhibitor | |||
| 0.216 | 0.005 | 0.216 | NMDA 2C receptor antagonist | |||
| 0.218 | 0.008 | 0.218 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.217 | 0.008 | 0.217 | TRPA1 agonist | |||
| 0.227 | 0.02 | 0.227 | DNA intercalator | |||
| 0.209 | 0.003 | 0.209 | NMDA 2D receptor antagonist | |||
| 0.227 | 0.025 | 0.227 | Neurotensin receptor agonist | 0.207 0.031 CID_5288478 | ||
| 0.285 | 0.085 | 0.355 | Interleukin 2 agonist | 0.355 0.043 CID_5288478 | CID_5288478 | |
| 0.22 | 0.02 | 0.22 | GABA C receptor rho-2 antagonist | |||
| 0.227 | 0.027 | 0.227 | Heat shock protein 90 antagonist | |||
| 0.206 | 0.009 | 0.206 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.241 | 0.047 | 0.241 | Non-steroidal antiinflammatory agent | |||
| 0.201 | 0.008 | 0.201 | Argininosuccinate synthase inhibitor | 0.056 0.04 CID_5288478 | ||
| 0.233 | 0.04 | 0.233 | Amyloid beta precursor protein antagonist | |||
| 0.204 | 0.012 | 0.204 | Alcohol dehydrogenase inhibitor | 0.101 0.051 CID_5288478 | ||
| 0.2 | 0.009 | 0.2 | Potassium channel activator | |||
| 0.215 | 0.026 | 0.215 | Toll-Like receptor antagonist | |||
| 0.194 | 0.007 | 0.194 | Ornithine carbamoyltransferase inhibitor | 0.19 0.007 CID_5288478 | ||
| 0.197 | 0.01 | 0.222 | Glutamate dehydrogenase inhibitor | 0.222 0.009 CID_5288478 | CID_5288478 | |
| 0.286 | 0.1 | 0.286 | Cholesterol antagonist | |||
| 0.213 | 0.028 | 0.213 | Interleukin 1 antagonist | |||
| 0.196 | 0.013 | 0.196 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.185 | 0.004 | 0.185 | Bcl2 antagonist | 0.074 0.037 CID_5288478 | ||
| 0.186 | 0.006 | 0.426 | Glutathione S-transferase inhibitor | 0.426 0.002 CID_5288478 | CID_5288478 | |
| 0.182 | 0.003 | 0.182 | Kainate receptor 5 antagonist | |||
| 0.201 | 0.024 | 0.201 | Cystathionine beta-synthase inhibitor | |||
| 0.178 | 0.009 | 0.482 | Glutamate decarboxylase inhibitor | 0.482 0.002 CID_5288478 | CID_5288478 | |
| 0.18 | 0.012 | 0.18 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.255 | 0.091 | 0.287 | Insulysin inhibitor | 0.287 0.067 CID_5288478 | CID_5288478 | |
| 0.177 | 0.013 | 0.177 | NADH dehydrogenase inhibitor | |||
| 0.181 | 0.017 | 0.181 | GABA C receptor antagonist | |||
| 0.178 | 0.016 | 0.178 | Beta glucuronidase inhibitor | |||
| 0.236 | 0.075 | 0.236 | Free radical scavenger | 0.181 0.114 CID_5288478 | ||
| 0.172 | 0.012 | 0.172 | Ca2+-transporting ATPase inhibitor | |||
| 0.202 | 0.042 | 0.308 | Phospholipase C inhibitor | 0.308 0.018 CID_5288478 | CID_5288478 | |
| 0.175 | 0.018 | 0.175 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.181 | 0.024 | 0.181 | Xanthine oxidase inhibitor | |||
| 0.177 | 0.02 | 0.177 | Interleukin 8 antagonist | |||
| 0.162 | 0.006 | 0.162 | Purinergic P2X1 antagonist | |||
| 0.162 | 0.007 | 0.162 | NMDA receptor agonist | 0.126 0.012 CID_5288478 | ||
| 0.194 | 0.039 | 0.194 | Arachidonic acid antagonist | |||
| 0.171 | 0.017 | 0.171 | DNA repair enzyme inhibitor | |||
| 0.159 | 0.006 | 0.159 | GABA aminotransferase inhibitor | |||
| 0.167 | 0.015 | 0.167 | GABA C receptor rho-1 antagonist | |||
| 0.157 | 0.005 | 0.157 | D-Ala-D-Ala ligase inhibitor | |||
| 0.166 | 0.014 | 0.166 | Toll-Like receptor 4 antagonist | 0.118 0.046 CID_5288478 | ||
| 0.156 | 0.007 | 0.156 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.264 | 0.115 | 0.264 | Thyroid hormone antagonist | |||
| 0.152 | 0.004 | 0.152 | GABA B receptor agonist | |||
| 0.19 | 0.043 | 0.19 | Thiol protease inhibitor | 0.185 0.045 CID_5288478 | ||
| 0.245 | 0.098 | 0.48 | Immunostimulant | 0.48 0.032 CID_5288478 | CID_5288478 | |
| 0.152 | 0.006 | 0.152 | NMDA receptor subunit 3B antagonist | |||
| 0.149 | 0.005 | 0.149 | Glutamate (mGluR group III) agonist | |||
| 0.149 | 0.004 | 0.149 | NMDA receptor glycine site agonist | |||
| 0.152 | 0.01 | 0.152 | CDK9/cyclin T1 inhibitor | |||
| 0.161 | 0.02 | 0.161 | Carbonic anhydrase XIII inhibitor | |||
| 0.161 | 0.02 | 0.161 | Androgen antagonist | |||
| 0.151 | 0.011 | 0.151 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.142 | 0.003 | 0.142 | Kainate receptor 4 antagonist | |||
| 0.142 | 0.005 | 0.142 | Plasminogen activator inhibitor antagonist | |||
| 0.167 | 0.03 | 0.167 | Pregnane X receptor agonist | |||
| 0.151 | 0.016 | 0.151 | NMDA 2 receptor antagonist | |||
| 0.139 | 0.004 | 0.139 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.137 | 0.002 | 0.137 | Glutamate (mGluR8) agonist | 0.052 0.01 CID_5288478 | ||
| 0.141 | 0.006 | 0.141 | AMPA receptor antagonist | |||
| 0.217 | 0.083 | 0.217 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.156 | 0.022 | 0.156 | NMDA receptor antagonist | |||
| 0.175 | 0.041 | 0.175 | Calcium channel blocker | |||
| 0.15 | 0.016 | 0.15 | Acetylcholine release stimulant | |||
| 0.136 | 0.003 | 0.136 | Kainate receptor 3 antagonist | 0.017 0.012 CID_5288478 | ||
| 0.16 | 0.028 | 0.16 | Heat shock protein 70 antagonist | |||
| 0.251 | 0.118 | 0.251 | Thyroid hormone beta antagonist | |||
| 0.197 | 0.065 | 0.197 | Growth factor agonist | |||
| 0.147 | 0.015 | 0.147 | Carbonic anhydrase V inhibitor | |||
| 0.136 | 0.005 | 0.136 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.157 | 0.027 | 0.157 | Photosensitizer | |||
| 0.145 | 0.018 | 0.145 | CYP2A6 inhibitor | |||
| 0.132 | 0.004 | 0.132 | Glutamate (mGluR4) antagonist | |||
| 0.168 | 0.041 | 0.168 | Anesthetic local | |||
| 0.182 | 0.055 | 0.182 | ATPase inhibitor | |||
| 0.148 | 0.021 | 0.148 | Carbonic anhydrase VI inhibitor | |||
| 0.243 | 0.118 | 0.243 | Caspase 3 stimulant | |||
| 0.156 | 0.032 | 0.156 | 5 Hydroxytryptamine 3A agonist | |||
| 0.177 | 0.052 | 0.177 | Interferon gamma antagonist | |||
| 0.214 | 0.091 | 0.214 | Dyrk kinase inhibitor | |||
| 0.161 | 0.038 | 0.161 | Antibacterial (Helicobacter pylori) | |||
| 0.135 | 0.012 | 0.135 | Glycine receptor antagonist | |||
| 0.137 | 0.014 | 0.137 | Carbonic anhydrase VA inhibitor | |||
| 0.131 | 0.009 | 0.131 | Glutamate (mGluR1) antagonist | |||
| 0.175 | 0.053 | 0.175 | Protein kinase stimulant | |||
| 0.147 | 0.027 | 0.189 | Catalase inhibitor | 0.189 0.017 CID_5288478 | CID_5288478 | |
| 0.169 | 0.049 | 0.169 | Cytokine production inhibitor | |||
| 0.129 | 0.009 | 0.129 | Androgen agonist | |||
| 0.122 | 0.004 | 0.122 | Ryanodine receptor antagonist | |||
| 0.145 | 0.027 | 0.145 | Transcription factor STAT6 inhibitor | |||
| 0.123 | 0.005 | 0.123 | Kainate receptor antagonist | 0.122 0.005 CID_5288478 | ||
| 0.122 | 0.004 | 0.122 | Sodium/calcium exchanger inhibitor | |||
| 0.13 | 0.014 | 0.13 | Calcium channel L-type blocker | |||
| 0.14 | 0.024 | 0.14 | Anabolic | |||
| 0.122 | 0.006 | 0.122 | Cathepsin L2 inhibitor | |||
| 0.129 | 0.014 | 0.129 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.13 | 0.015 | 0.13 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.12 | 0.005 | 0.12 | AMPA 2 receptor antagonist | 0.035 0.017 CID_5288478 | ||
| 0.245 | 0.131 | 0.245 | Transcription factor NF kappa B inhibitor | |||
| 0.117 | 0.004 | 0.117 | Nitric oxide donor | 0.081 0.021 CID_5288478 | ||
| 0.119 | 0.007 | 0.119 | NMDA receptor subunit 3A antagonist | |||
| 0.171 | 0.059 | 0.171 | Melanin inhibitor | |||
| 0.122 | 0.01 | 0.122 | Maillard reaction inhibitor | |||
| 0.159 | 0.049 | 0.159 | Adenylate cyclase stimulant | |||
| 0.115 | 0.005 | 0.115 | Exportin-1 inhibitor | |||
| 0.115 | 0.005 | 0.115 | CDK7/cyclin H inhibitor | |||
| 0.178 | 0.069 | 0.178 | Tumour necrosis factor antagonist | |||
| 0.138 | 0.028 | 0.138 | Nitric-oxide synthase inhibitor | |||
| 0.136 | 0.026 | 0.154 | Factor V inhibitor | 0.154 0.017 CID_5288478 | CID_5288478 | |
| 0.115 | 0.007 | 0.115 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.21 | 0.103 | 0.21 | Neuropeptide Y2 antagonist | |||
| 0.188 | 0.081 | 0.188 | I kappa B kinase epsilon inhibitor | |||
| 0.141 | 0.035 | 0.141 | Caspase 3 inhibitor | |||
| 0.119 | 0.013 | 0.119 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.11 | 0.005 | 0.11 | Glutamate (mGluR group III) antagonist | |||
| 0.11 | 0.005 | 0.11 | Alpha-mannosidase inhibitor | 0.049 0.047 CID_5288478 | ||
| 0.109 | 0.005 | 0.109 | Collagenase inhibitor | 0.055 0.023 CID_5288478 | ||
| 0.108 | 0.005 | 0.108 | Transcription factor RelA inhibitor | |||
| 0.112 | 0.01 | 0.112 | NMDA 2A receptor antagonist | 0.064 0.027 CID_5288478 | ||
| 0.12 | 0.018 | 0.12 | Aromatase inhibitor | |||
| 0.106 | 0.004 | 0.106 | Potassium channel (Inward rectifier) activator | |||
| 0.106 | 0.005 | 0.106 | Mannosidase inhibitor | |||
| 0.225 | 0.124 | 0.225 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.107 | 0.006 | 0.107 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.154 | 0.053 | 0.154 | M17 leucyl aminopeptidase inhibitor | |||
| 0.144 | 0.044 | 0.144 | Interleukin 1b antagonist | |||
| 0.137 | 0.037 | 0.137 | CDK3/cyclin E inhibitor | |||
| 0.103 | 0.004 | 0.103 | Potassium channel (ATP-sensitive) activator | |||
| 0.117 | 0.018 | 0.117 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.159 | 0.06 | 0.159 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.147 | 0.048 | 0.147 | Monophenol monooxygenase inhibitor | |||
| 0.103 | 0.004 | 0.103 | Kainate receptor 2 antagonist | |||
| 0.109 | 0.011 | 0.109 | Vanilloid 4 agonist | |||
| 0.102 | 0.004 | 0.102 | Glutamate (mGluR4) agonist | |||
| 0.124 | 0.027 | 0.124 | Histamine N-methyltransferase inhibitor | |||
| 0.109 | 0.013 | 0.109 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.102 | 0.006 | 0.102 | MDM2 inhibitor | |||
| 0.104 | 0.008 | 0.104 | Aconitate hydratase inhibitor | |||
| 0.102 | 0.006 | 0.102 | Bcl-xL inhibitor | 0.075 0.014 CID_5288478 | ||
| 0.15 | 0.055 | 0.15 | Acetylcholinesterase inhibitor | |||
| 0.099 | 0.005 | 0.099 | Dihydroorotate oxidase inhibitor | |||
| 0.116 | 0.023 | 0.116 | CDK2/cyclin E2 inhibitor | |||
| 0.125 | 0.033 | 0.125 | Electrolyte absorption antagonist | |||
| 0.093 | 0.003 | 0.093 | Nerve growth factor antagonist | |||
| 0.179 | 0.089 | 0.179 | Focal adhesion kinase 2 inhibitor | |||
| 0.093 | 0.005 | 0.093 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.094 | 0.006 | 0.094 | AMPA 1 receptor antagonist | 0.089 0.006 CID_5288478 | ||
| 0.135 | 0.047 | 0.135 | Alpha 2b adrenoreceptor antagonist | |||
| 0.131 | 0.044 | 0.131 | Protein kinase C gamma inhibitor | |||
| 0.093 | 0.006 | 0.093 | Lysophosphatidic acid 3 receptor antagonist | 0.053 0.03 CID_5288478 | ||
| 0.097 | 0.01 | 0.097 | Botulinum neurotoxin type A inhibitor | 0.061 0.036 CID_5288478 | ||
| 0.181 | 0.095 | 0.181 | MAP kinase kinase 2 inhibitor | |||
| 0.091 | 0.006 | 0.091 | AICAR transformylase inhibitor | 0.046 0.028 CID_5288478 | ||
| 0.101 | 0.016 | 0.101 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.126 | 0.042 | 0.126 | Carbonic anhydrase XV inhibitor | |||
| 0.089 | 0.005 | 0.089 | AMPA 4 receptor antagonist | 0.063 0.009 CID_5288478 | ||
| 0.105 | 0.021 | 0.105 | CDK2/cyclin E inhibitor | |||
| 0.15 | 0.067 | 0.15 | MAP kinase 3 inhibitor | |||
| 0.111 | 0.029 | 0.111 | Inducible nitric-oxide synthase inhibitor | |||
| 0.125 | 0.043 | 0.125 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.105 | 0.024 | 0.105 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.09 | 0.009 | 0.09 | Calcium channel P-type blocker | |||
| 0.097 | 0.017 | 0.097 | Carbonic anhydrase VB inhibitor | |||
| 0.089 | 0.01 | 0.089 | CD45 antagonist | 0.066 0.017 CID_5288478 | ||
| 0.084 | 0.006 | 0.084 | Dihydropteroate synthase inhibitor | |||
| 0.084 | 0.006 | 0.084 | Thymidylate synthase inhibitor | 0.08 0.007 CID_5288478 | ||
| 0.081 | 0.004 | 0.081 | Kainate receptor agonist | |||
| 0.106 | 0.029 | 0.106 | Histamine H2 receptor antagonist | |||
| 0.102 | 0.027 | 0.102 | Interferon agonist | |||
| 0.176 | 0.102 | 0.176 | Neurotrophic factor enhancer | |||
| 0.077 | 0.004 | 0.077 | Heme oxygenase inhibitor | |||
| 0.081 | 0.008 | 0.081 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.1 | 0.027 | 0.1 | Carbonic anhydrase inhibitor | |||
| 0.077 | 0.004 | 0.077 | Cyclophilin A inhibitor | |||
| 0.114 | 0.043 | 0.114 | Prolactin inhibitor | |||
| 0.098 | 0.027 | 0.098 | T cell inhibitor | |||
| 0.092 | 0.022 | 0.092 | Carbonic anhydrase XII inhibitor | |||
| 0.089 | 0.019 | 0.089 | Glutamate (mGluR7) antagonist | |||
| 0.088 | 0.018 | 0.088 | Interferon inducer | |||
| 0.076 | 0.007 | 0.076 | GABA B receptor antagonist | |||
| 0.144 | 0.075 | 0.144 | Neuropeptide Y1 antagonist | |||
| 0.133 | 0.064 | 0.133 | Cyclooxygenase 3 inhibitor | |||
| 0.084 | 0.016 | 0.084 | Cyclin H inhibitor | |||
| 0.098 | 0.029 | 0.158 | Aminopeptidase I inhibitor | 0.158 0.011 CID_5288478 | CID_5288478 | |
| 0.106 | 0.037 | 0.106 | Bile acid receptor antagonist | |||
| 0.112 | 0.043 | 0.112 | MAP kinase kinase 1 inhibitor | |||
| 0.072 | 0.005 | 0.072 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.075 | 0.008 | 0.075 | Fumarate hydratase inhibitor | |||
| 0.099 | 0.032 | 0.099 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.089 | 0.023 | 0.089 | Carbonic anhydrase IX inhibitor | |||
| 0.07 | 0.004 | 0.07 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.103 | 0.038 | 0.103 | Glutamate release inhibitor | |||
| 0.069 | 0.004 | 0.069 | NMDA receptor glycine site antagonist | |||
| 0.121 | 0.056 | 0.121 | Calcium channel (voltage-sensitive) blocker | |||
| 0.071 | 0.006 | 0.071 | Potassium channel Kv1.1 blocker | |||
| 0.082 | 0.018 | 0.082 | Fatty acid synthase inhibitor | |||
| 0.122 | 0.058 | 0.122 | Microtubule formation inhibitor | |||
| 0.097 | 0.034 | 0.097 | Na+ K+ transporting ATPase inhibitor | |||
| 0.069 | 0.006 | 0.069 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.111 | 0.048 | 0.111 | Sphingomyelinase inhibitor | |||
| 0.125 | 0.062 | 0.125 | Beta amyloid protein antagonist | |||
| 0.067 | 0.005 | 0.067 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.072 | 0.01 | 0.072 | Immunoglobulin Fc receptor antagonist | |||
| 0.072 | 0.01 | 0.072 | Phosphodiesterase 7A inhibitor | |||
| 0.066 | 0.004 | 0.066 | Kainate receptor 1 antagonist | 0.034 0.009 CID_5288478 | ||
| 0.092 | 0.03 | 0.092 | Benzodiazepine agonist | |||
| 0.084 | 0.023 | 0.084 | Carbonic anhydrase I inhibitor | |||
| 0.154 | 0.094 | 0.154 | LIM domain kinase 1 inhibitor | |||
| 0.094 | 0.034 | 0.094 | Estrogen-related receptor beta agonist | |||
| 0.082 | 0.022 | 0.082 | Glutamate (mGluR6) antagonist | |||
| 0.097 | 0.038 | 0.097 | Myeloperoxidase inhibitor | |||
| 0.077 | 0.018 | 0.077 | Carbonic anhydrase XIV inhibitor | |||
| 0.069 | 0.01 | 0.069 | Histamine H2 receptor agonist | |||
| 0.069 | 0.01 | 0.069 | Purinergic P2X4 antagonist | |||
| 0.216 | 0.158 | 0.293 | Antithrombotic | 0.293 0.093 CID_5288478 | CID_5288478 | |
| 0.142 | 0.083 | 0.189 | Phospholipase A2 inhibitor | 0.189 0.049 CID_5288478 | CID_5288478 | |
| 0.061 | 0.004 | 0.061 | Human T-cell leukemia virus type I protease inhibitor | |||
| 0.088 | 0.031 | 0.088 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.071 | 0.015 | 0.071 | Oleamide hydrolase inhibitor | |||
| 0.083 | 0.027 | 0.083 | Potassium channel (Tandem pore domain) blocker | |||
| 0.08 | 0.024 | 0.08 | Xanthine dehydrogenase inhibitor | |||
| 0.074 | 0.019 | 0.201 | Glycine transporter 2 inhibitor | 0.201 0.005 CID_5288478 | CID_5288478 | |
| 0.062 | 0.007 | 0.062 | Integrin alpha2 antagonist | |||
| 0.11 | 0.055 | 0.11 | Protein kinase (CK2) inhibitor | |||
| 0.061 | 0.006 | 0.061 | AMPA 3 receptor antagonist | 0.032 0.019 CID_5288478 | ||
| 0.08 | 0.025 | 0.08 | Carbonic anhydrase II inhibitor | |||
| 0.08 | 0.026 | 0.08 | Phosphodiesterase VII inhibitor | |||
| 0.139 | 0.085 | 0.139 | Acetylcholine M1 receptor antagonist | |||
| 0.111 | 0.057 | 0.111 | Alpha 2c adrenoreceptor antagonist | |||
| 0.097 | 0.044 | 0.097 | Bcr-Abl kinase inhibitor | |||
| 0.085 | 0.032 | 0.085 | Glycine receptor agonist | |||
| 0.083 | 0.03 | 0.11 | Neutrophil collagenase inhibitor | 0.11 0.019 CID_5288478 | CID_5288478 | |
| 0.087 | 0.034 | 0.087 | Prostaglandin-E synthase inhibitor | |||
| 0.09 | 0.038 | 0.09 | CC chemokine 5 receptor agonist | |||
| 0.057 | 0.006 | 0.057 | Uridine phosphorylase inhibitor | |||
| 0.071 | 0.02 | 0.071 | Phosphorylase inhibitor | |||
| 0.064 | 0.013 | 0.064 | CDK5/p25 inhibitor | |||
| 0.102 | 0.051 | 0.102 | Potassium channel (Voltage-sensitive) activator | |||
| 0.222 | 0.172 | 0.222 | Beta lactamase inhibitor | |||
| 0.088 | 0.038 | 0.088 | Cathepsin G inhibitor | |||
| 0.059 | 0.01 | 0.059 | GABA uptake inhibitor | |||
| 0.114 | 0.066 | 0.114 | Protein kinase (CK2) alpha inhibitor | |||
| 0.081 | 0.033 | 0.081 | Phospholipase D inhibitor | |||
| 0.265 | 0.217 | 0.265 | MAP kinase 1 inhibitor | |||
| 0.124 | 0.079 | 0.125 | Vanilloid 1 agonist | 0.125 0.077 CID_5288478 | CID_5288478 | |
| 0.054 | 0.009 | 0.054 | Purinergic P2Y2 antagonist | |||
| 0.115 | 0.07 | 0.115 | Proteasome inhibitor | 0.101 0.086 CID_5288478 | ||
| 0.048 | 0.004 | 0.048 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.083 | 0.039 | 0.083 | MAP kinase kinase 7 inhibitor | |||
| 0.048 | 0.005 | 0.048 | Adenosine uptake inhibitor | |||
| 0.075 | 0.031 | 0.075 | Protease 3C (Human rhinovirus) inhibitor | 0.073 0.034 CID_5288478 | ||
| 0.046 | 0.003 | 0.046 | Complement factor 1s inhibitor | |||
| 0.056 | 0.014 | 0.056 | Dopamine D5 agonist | |||
| 0.055 | 0.013 | 0.055 | TRPM8 blocker | |||
| 0.055 | 0.013 | 0.055 | Alpha 1d adrenoreceptor agonist | |||
| 0.105 | 0.064 | 0.105 | AMP-activated protein kinase stimulant | |||
| 0.045 | 0.004 | 0.045 | Estrogen-related receptor gamma antagonist | |||
| 0.053 | 0.012 | 0.053 | Bombesin 1 receptor antagonist | |||
| 0.064 | 0.023 | 0.064 | Pregnane X receptor antagonist | |||
| 0.079 | 0.039 | 0.079 | Glutamate (mGluR group I) antagonist | |||
| 0.1 | 0.06 | 0.1 | Glutamate (mGluR7) agonist | |||
| 0.062 | 0.022 | 0.062 | Potassium channel (Inward rectifier) blocker | |||
| 0.077 | 0.037 | 0.077 | Acetylcholine M5 receptor agonist | |||
| 0.049 | 0.01 | 0.049 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.067 | 0.028 | 0.067 | Prolactin release inhibitor | |||
| 0.054 | 0.017 | 0.054 | Guanylate cyclase inhibitor | |||
| 0.131 | 0.094 | 0.131 | Diuretic | |||
| 0.057 | 0.021 | 0.25 | Toll-Like receptor 2 agonist | 0.25 0.004 CID_5288478 | CID_5288478 | |
| 0.041 | 0.004 | 0.041 | Acid ceramidase inhibitor | |||
| 0.045 | 0.009 | 0.045 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.042 | 0.006 | 0.042 | Thymidine phosphorylase inhibitor | |||
| 0.083 | 0.048 | 0.083 | Macrophage migration inhibitory factor inhibitor | |||
| 0.052 | 0.016 | 0.052 | Dihydrofolate reductase inhibitor | |||
| 0.037 | 0.003 | 0.037 | Glutamate (mGluR6) agonist | 0.016 0.005 CID_5288478 | ||
| 0.07 | 0.036 | 0.07 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.037 | 0.004 | 0.037 | Progesterone receptor B antagonist | |||
| 0.039 | 0.005 | 0.039 | Glutamate (mGluR1) agonist | |||
| 0.038 | 0.005 | 0.038 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.048 | 0.015 | 0.048 | Phosphoglycerate kinase inhibitor | |||
| 0.049 | 0.016 | 0.049 | Vascular adhesion protein 1 inhibitor | |||
| 0.049 | 0.016 | 0.049 | Factor XIIIa inhibitor | |||
| 0.075 | 0.043 | 0.075 | CDK1/cyclin B1 inhibitor | |||
| 0.055 | 0.023 | 0.055 | Aldosterone antagonist | |||
| 0.039 | 0.006 | 0.039 | Integrin alpha2beta1 antagonist | |||
| 0.035 | 0.003 | 0.035 | Thromboxane A2 agonist | |||
| 0.05 | 0.018 | 0.05 | Histamine H1 receptor agonist | |||
| 0.041 | 0.01 | 0.041 | Epoxide hydrolase 1 inhibitor | |||
| 0.053 | 0.023 | 0.053 | Carbonic anhydrase IV inhibitor | |||
| 0.065 | 0.035 | 0.065 | Cyclin D1 inhibitor | |||
| 0.077 | 0.046 | 0.114 | Metalloproteinase-9 inhibitor | 0.114 0.027 CID_5288478 | CID_5288478 | |
| 0.077 | 0.047 | 0.077 | Adenosine A3 receptor antagonist | |||
| 0.043 | 0.014 | 0.043 | Free fatty acid receptor 1 antagonist | |||
| 0.063 | 0.034 | 0.063 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.067 | 0.039 | 0.067 | Neuraminidase (influenza) inhibitor | |||
| 0.033 | 0.004 | 0.033 | Factor XIII inhibitor | |||
| 0.039 | 0.01 | 0.039 | CDK4/cyclin D3 inhibitor | |||
| 0.053 | 0.025 | 0.053 | Dopamine beta hydroxylase inhibitor | |||
| 0.06 | 0.032 | 0.06 | Aldose reductase inhibitor | |||
| 0.107 | 0.079 | 0.107 | Cholesterol synthesis inhibitor | |||
| 0.09 | 0.062 | 0.09 | Polo-like kinase-1 inhibitor | |||
| 0.123 | 0.096 | 0.123 | Farnesoid X receptor antagonist | |||
| 0.13 | 0.103 | 0.13 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.038 | 0.012 | 0.038 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.051 | 0.026 | 0.051 | Cytokine production stimulant | |||
| 0.054 | 0.029 | 0.058 | Bombesin 2 receptor antagonist | 0.058 0.026 CID_5288478 | CID_5288478 | |
| 0.035 | 0.011 | 0.035 | Purinergic P2Y15 antagonist | |||
| 0.145 | 0.121 | 0.145 | Psychostimulant | |||
| 0.144 | 0.121 | 0.144 | Death-associated protein kinase 2 inhibitor | |||
| 0.055 | 0.032 | 0.055 | Thromboxane A2 antagonist | |||
| 0.053 | 0.03 | 0.053 | Squalene epoxidase inhibitor | |||
| 0.042 | 0.019 | 0.042 | CF transmembrane conductance regulator antagonist | |||
| 0.05 | 0.027 | 0.05 | Carbonic anhydrase VII inhibitor | |||
| 0.063 | 0.04 | 0.063 | TRPA1 antagonist | |||
| 0.055 | 0.033 | 0.055 | Autotaxin inhibitor | |||
| 0.063 | 0.041 | 0.063 | Caspase 9 inhibitor | 0.063 0.042 CID_5288478 | ||
| 0.045 | 0.023 | 0.045 | Thymidine kinase inhibitor | |||
| 0.133 | 0.111 | 0.133 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.049 | 0.028 | 0.049 | Adenylate cyclase 1 inhibitor | |||
| 0.027 | 0.008 | 0.027 | Isoleucine-tRNA ligase inhibitor | |||
| 0.09 | 0.071 | 0.09 | MAO A inhibitor | |||
| 0.032 | 0.013 | 0.032 | LFA antagonist | |||
| 0.075 | 0.056 | 0.075 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.055 | 0.036 | 0.055 | Thromboxane antagonist | |||
| 0.098 | 0.079 | 0.098 | GABA receptor agonist | |||
| 0.022 | 0.004 | 0.022 | Carbonic anhydrase XI inhibitor | |||
| 0.039 | 0.021 | 0.039 | Nicotinic acid receptor agonist | |||
| 0.082 | 0.064 | 0.082 | mTOR complex 2 inhibitor | |||
| 0.04 | 0.022 | 0.04 | Progesterone antagonist | |||
| 0.059 | 0.041 | 0.059 | Carbonic anhydrase stimulant | |||
| 0.021 | 0.003 | 0.021 | Progesterone receptor A antagonist | |||
| 0.022 | 0.004 | 0.022 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.082 | 0.065 | 0.082 | Ornithine decarboxylase inhibitor | |||
| 0.054 | 0.038 | 0.054 | Thromboxane synthase inhibitor | |||
| 0.032 | 0.015 | 0.032 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.029 | 0.012 | 0.029 | Complement factor 1r inhibitor | |||
| 0.045 | 0.029 | 0.045 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.028 | 0.012 | 0.028 | Vanilloid 2 agonist | |||
| 0.074 | 0.058 | 0.074 | Keratolytic | |||
| 0.041 | 0.025 | 0.041 | Urate transporter 1 inhibitor | |||
| 0.053 | 0.037 | 0.053 | GABA A receptor antagonist | |||
| 0.054 | 0.039 | 0.054 | GABA receptor antagonist | |||
| 0.074 | 0.059 | 0.141 | Metalloproteinase-2 inhibitor | 0.141 0.021 CID_5288478 | CID_5288478 | |
| 0.155 | 0.14 | 0.155 | Antiamyloidogenic | |||
| 0.034 | 0.019 | 0.034 | Glutamate (mGluR3) agonist | |||
| 0.055 | 0.04 | 0.055 | 5 Hydroxytryptamine 7 agonist | |||
| 0.058 | 0.044 | 0.058 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.079 | 0.065 | 0.079 | Caspase 7 inhibitor | |||
| 0.056 | 0.042 | 0.056 | Adenosine A1 receptor antagonist | |||
| 0.085 | 0.071 | 0.085 | MAO B inhibitor | |||
| 0.096 | 0.083 | 0.167 | Mucolytic | 0.167 0.024 CID_5288478 | CID_5288478 | |
| 0.048 | 0.034 | 0.048 | Histamine H4 receptor antagonist | |||
| 0.02 | 0.007 | 0.02 | Purinergic P2Y1 agonist | |||
| 0.021 | 0.007 | 0.021 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.025 | 0.012 | 0.025 | ICAM 1 antagonist | |||
| 0.081 | 0.069 | 0.081 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.047 | 0.034 | 0.047 | Benzodiazepine antagonist | |||
| 0.101 | 0.089 | 0.101 | MAO inhibitor | |||
| 0.042 | 0.03 | 0.042 | Angiotensin AT1 receptor antagonist | |||
| 0.039 | 0.027 | 0.057 | Membrane dipeptidase inhibitor | 0.057 0.011 CID_5288478 | CID_5288478 | |
| 0.064 | 0.052 | 0.064 | Potassium channel (ATP-sensitive) blocker | |||
| 0.062 | 0.051 | 0.062 | Beta adrenoreceptor antagonist | |||
| 0.057 | 0.046 | 0.057 | Alpha 2 adrenoreceptor agonist | |||
| 0.023 | 0.012 | 0.023 | Imidazoline I1 receptor antagonist | |||
| 0.048 | 0.037 | 0.048 | Topoisomerase II beta inhibitor | |||
| 0.028 | 0.017 | 0.028 | Nicotinic acid receptor 2 antagonist | |||
| 0.027 | 0.016 | 0.027 | Prostaglandin H2 antagonist | |||
| 0.022 | 0.011 | 0.022 | Retinoid X beta receptor antagonist | |||
| 0.029 | 0.019 | 0.029 | MAP3K8 inhibitor | |||
| 0.017 | 0.007 | 0.017 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.051 | 0.041 | 0.051 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.053 | 0.043 | 0.053 | Epithelial sodium channel blocker | |||
| 0.018 | 0.008 | 0.018 | CDK2/cyclin A3 inhibitor | |||
| 0.015 | 0.005 | 0.015 | Thromboxane agonist | |||
| 0.037 | 0.028 | 0.037 | DNA gyrase subunit B inhibitor | |||
| 0.145 | 0.135 | 0.145 | Anticonvulsant | |||
| 0.052 | 0.043 | 0.052 | Glucosylceramidase inhibitor | |||
| 0.05 | 0.041 | 0.086 | Ribonucleoside-diphosphate reductase inhibitor | 0.086 0.023 CID_5288478 | CID_5288478 | |
| 0.019 | 0.01 | 0.019 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.018 | 0.01 | 0.018 | Carbonic anhydrase VIII inhibitor | |||
| 0.018 | 0.01 | 0.018 | Carbonic anhydrase X inhibitor | |||
| 0.059 | 0.051 | 0.059 | Histone deacetylase SIRT3 inhibitor | |||
| 0.033 | 0.024 | 0.033 | Protein kinase (CK2) beta inhibitor | |||
| 0.018 | 0.01 | 0.018 | Telomerase stimulant | |||
| 0.019 | 0.011 | 0.019 | CXC chemokine 5 receptor antagonist | |||
| 0.021 | 0.014 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.026 | 0.019 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.112 | 0.104 | 0.112 | CDC-like kinase 1 inhibitor | |||
| 0.036 | 0.029 | 0.036 | Diamine oxidase inhibitor | |||
| 0.038 | 0.031 | 0.038 | VCAM-1 antagonist | |||
| 0.058 | 0.051 | 0.058 | 5 Hydroxytryptamine 3 agonist | |||
| 0.049 | 0.043 | 0.086 | Ribonucleotide reductase inhibitor | 0.086 0.024 CID_5288478 | CID_5288478 | |
| 0.038 | 0.032 | 0.038 | VCAM antagonist | |||
| 0.026 | 0.019 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.017 | 0.011 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | |||
| 0.022 | 0.016 | 0.022 | Glutamate (mGluR1a) agonist | |||
| 0.016 | 0.01 | 0.016 | Antibiotic Tetracycline-like | |||
| 0.041 | 0.035 | 0.041 | Geranyltranstransferase inhibitor | |||
| 0.028 | 0.022 | 0.028 | 5 Hydroxytryptamine 6 agonist | |||
| 0.036 | 0.031 | 0.036 | Cathepsin L1 inhibitor | |||
| 0.024 | 0.019 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.046 | 0.042 | 0.046 | Prolyl endopeptidase inhibitor | |||
| 0.042 | 0.038 | 0.066 | Antimetabolite | 0.066 0.023 CID_5288478 | CID_5288478 | |
| 0.026 | 0.022 | 0.026 | Hedgehog signaling activator | |||
| 0.052 | 0.048 | 0.052 | Cathepsin L inhibitor | |||
| 0.056 | 0.052 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.008 | 0.004 | 0.008 | Integrin alpha5beta6 antagonist | |||
| 0.066 | 0.063 | 0.066 | Alpha 2a adrenoreceptor antagonist | |||
| 0.041 | 0.039 | 0.041 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.1 | 0.098 | 0.1 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.014 | 0.013 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.004 | 0.003 | 0.004 | Human herpesvirus 2 protease inhibitor | |||
| 0.012 | 0.011 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.007 | 0.006 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.028 | 0.026 | 0.028 | Potassium channel small-conductance Ca-activated activator | |||
| 0.011 | 0.01 | 0.011 | Integrin beta2 antagonist | |||
| 0.01 | 0.009 | 0.01 | Purinergic P2Y2 agonist | |||
| 0.016 | 0.015 | 0.016 | Cyclin T1 inhibitor | |||
| 0.012 | 0.011 | 0.012 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.041 | 0.04 | 0.041 | Glutamate (mGluR5) agonist | |||
| 0.024 | 0.023 | 0.024 | CXC chemokine 2 receptor antagonist | |||
| 0.102 | 0.102 | 0.133 | Toll-Like receptor 2 antagonist | 0.133 0.065 CID_5288478 | CID_5288478 | |
| 0.141 | 0.145 | 0.184 | Insulin sensitizer | 0.184 0.091 CID_5288478 | CID_5288478 | |
| 0.04 | 0.045 | 0.062 | Matrix metalloproteinase 1 inhibitor | 0.062 0.03 CID_5288478 | CID_5288478 | |
| 0.021 | 0.029 | 0.041 | Lysine carboxypeptidase inhibitor | 0.041 0.01 CID_5288478 | CID_5288478 | |
| 0.027 | 0.043 | 0.034 | Carboxypeptidase B inhibitor | 0.034 0.022 CID_5288478 | CID_5288478 | |
| 0.01 | 0.029 | 0.024 | Aminopeptidase A inhibitor | 0.024 0.008 CID_5288478 | CID_5288478 | |
| 0.048 | 0.068 | 0.091 | Matrix metalloproteinase inhibitor | 0.091 0.031 CID_5288478 | CID_5288478 | |
| 0.071 | 0.094 | 0.094 | Transcription factor NF kappa B stimulant | 0.094 0.045 CID_5288478 | CID_5288478 | |
| 0.02 | 0.044 | 0.042 | Arginase inhibitor | 0.042 0.021 CID_5288478 | CID_5288478 | |
| 0.073 | 0.108 | 0.185 | Expectorant | 0.185 0.024 CID_5288478 | CID_5288478 | |
| 0.033 | 0.076 | 0.044 | Bombesin antagonist | 0.044 0.04 CID_5288478 | CID_5288478 | |
| 0.059 | 0.102 | 0.08 | Chymotrypsin inhibitor | 0.08 0.055 CID_5288478 | CID_5288478 | |
| 0.109 | 0.171 | 0.432 | Interleukin antagonist | 0.432 0.026 CID_5288478 | CID_5288478 | |
| 0.024 | 0.099 | 0.046 | Neuropeptide agonist | 0.046 0.045 CID_5288478 | CID_5288478 | |
| 0.006 | 0.085 | 0.694 | Integrin alphaLbeta2 antagonist | 0.694 0.001 CID_5288478 | CID_5288478 | |
| 0.067 | 0.147 | 0.132 | Histone deacetylase class III inhibitor | 0.132 0.059 CID_5288478 | CID_5288478 | |
| 0.059 | 0.155 | 0.15 | Chelator | 0.15 0.035 CID_5288478 | CID_5288478 | |
| 0.076 | 0.179 | 0.185 | Histone deacetylase SIRT1 inhibitor | 0.185 0.037 CID_5288478 | CID_5288478 | |
| 0.115 | 0.219 | 0.166 | Antioxidant | 0.166 0.146 CID_5288478 | CID_5288478 | |
| 0.01 | 0.131 | 0.028 | Caspase 2 inhibitor | 0.028 0.025 CID_5288478 | CID_5288478 | |
| 0.016 | 0.146 | 0.054 | Aminopeptidase N inhibitor | 0.054 0.028 CID_5288478 | CID_5288478 | |
| 0.023 | 0.161 | 0.073 | Aminopeptidase microsomal inhibitor | 0.073 0.029 CID_5288478 | CID_5288478 | |
| 0.027 | 0.203 | 0.063 | Cathepsin B inhibitor | 0.063 0.033 CID_5288478 | CID_5288478 | |
| 0.128 | 0.333 | 0.26 | Apoptosis antagonist | 0.26 0.118 CID_5288478 | CID_5288478 | |
| 0.05 | 0.288 | 0.147 | Hematopoietic | 0.147 0.015 CID_5288478 | CID_5288478 | |
| 0.016 | 0.277 | 0.048 | Farnesyltransferase inhibitor | 0.048 0.029 CID_5288478 | CID_5288478 | |
| 0.045 | 0.321 | 0.395 | Angiogenesis stimulant | 0.395 0.022 CID_5288478 | CID_5288478 | |
| 0.033 | 0.323 | 0.103 | Factor XII inhibitor | 0.103 0.035 CID_5288478 | CID_5288478 | |
| 0.031 | 0.356 | 0.354 | Thrombolytic | 0.354 0.016 CID_5288478 | CID_5288478 | |
| 0.025 | 0.383 | 0.056 | Cathepsin E inhibitor | 0.056 0.047 CID_5288478 | CID_5288478 | |
| 0.02 | 0.384 | 0.126 | Protease inhibitor | 0.126 0.043 CID_5288478 | CID_5288478 | |
| 0.042 | 0.519 | 0.216 | Hepatoprotectant | 0.216 0.056 CID_5288478 | CID_5288478 | |
| 0.001 | 0.526 | 0.017 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.017 0.009 CID_5288478 | CID_5288478 | |
| 0.004 | 0.533 | 0.08 | Leukotriene A4 hydrolase inhibitor | 0.08 0.009 CID_5288478 | CID_5288478 | |
| 0.02 | 0.577 | 0.462 | Platelet antagonist | 0.462 0.018 CID_5288478 | CID_5288478 | |
| 0.006 | 0.598 | 0.043 | Integrin alpha5beta1 antagonist | 0.043 0.025 CID_5288478 | CID_5288478 | |
| 0.006 | 0.624 | 0.039 | Carbonic anhydrase I stimulant | 0.039 0.025 CID_5288478 | CID_5288478 | |
| 0.009 | 0.697 | 0.08 | Sirtuin 1 inhibitor | 0.08 0.035 CID_5288478 | CID_5288478 | |
| 0.007 | 0.713 | 0.071 | Cell adhesion molecule inhibitor | 0.071 0.067 CID_5288478 | CID_5288478 | |
| 0.008 | 0.717 | 0.369 | Purinergic P2X2 antagonist | 0.369 0.001 CID_5288478 | CID_5288478 | |
| 0.016 | 0.753 | 0.105 | Nav1.4 sodium channel blocker | 0.105 0.069 CID_5288478 | CID_5288478 | |
| 0.004 | 0.784 | 0.548 | Integrin antagonist | 0.548 0.004 CID_5288478 | CID_5288478 | |
| 0.009 | 0.797 | 0.033 | HCV polyprotein inhibitor | 0.033 0.025 CID_5288478 | CID_5288478 | |
| 0.006 | 0.802 | 0.092 | Aminoacyl-tRNA synthetase inhibitor | 0.092 0.055 CID_5288478 | CID_5288478 | |
| 0.007 | 0.854 | 0.162 | Cell adhesion inhibitor | 0.162 0.039 CID_5288478 | CID_5288478 | |
| 0.003 | 0.858 | 0.084 | Angiotensin-converting enzyme inhibitor | 0.084 0.012 CID_5288478 | CID_5288478 | |
| 0.011 | 0.908 | 0.067 | Adenine nucleotide translocase inhibitor | 0.067 0.018 CID_5288478 | CID_5288478 | |
| 0.001 | 0.921 | 0.026 | Aminopeptidase P inhibitor | 0.026 0.013 CID_5288478 | CID_5288478 | |
| 0.004 | 0.926 | 0.059 | Endothelin-converting enzyme inhibitor | 0.059 0.025 CID_5288478 | CID_5288478 | |
| 0.003 | 0.93 | 0.08 | Selectin antagonist | 0.08 0.037 CID_5288478 | CID_5288478 | |
| 0.003 | 0.93 | 0.093 | Purinergic P2X3 antagonist | 0.093 0.005 CID_5288478 | CID_5288478 | |
| 0.006 | 0.949 | 0.056 | Bombesin 1 receptor agonist | 0.056 0.046 CID_5288478 | CID_5288478 | |
| 0.005 | 0.949 | 0.043 | Cathepsin F inhibitor | 0.043 0.025 CID_5288478 | CID_5288478 | |
| 0.006 | 0.956 | 0.042 | Glutamate (mGluR8) antagonist | 0.042 0.015 CID_5288478 | CID_5288478 | |
| 0.004 | 0.962 | 0.041 | Neurotensin receptor antagonist | 0.041 0.035 CID_5288478 | CID_5288478 | |
| 0.005 | 0.964 | 0.04 | Neurokinin 2 agonist | 0.04 0.03 CID_5288478 | CID_5288478 | |
| 0.006 | 0.968 | 0.08 | Somatostatin 1 agonist | 0.08 0.051 CID_5288478 | CID_5288478 | |
| 0.007 | 0.973 | 0.052 | Carbonic anhydrase II stimulant | 0.052 0.036 CID_5288478 | CID_5288478 | |
| 0.016 | 0.983 | 0.324 | Growth hormone agonist | 0.324 0.028 CID_5288478 | CID_5288478 | |
| 0.002 | 0.969 | 0.05 | GP IIb/IIIa receptor antagonist | 0.05 0.032 CID_5288478 | CID_5288478 | |
| 0.004 | 0.977 | 0.182 | Anticoagulant | 0.182 0.06 CID_5288478 | CID_5288478 | |
| 0.013 | 0.987 | 0.406 | Sodium/bile acid cotransporter inhibitor | 0.406 0.015 CID_5288478 | CID_5288478 | |
| 0.012 | 0.99 | 0.145 | Folate antagonist | 0.145 0.024 CID_5288478 | CID_5288478 | |
| 0.003 | 0.984 | 0.045 | Growth hormone release inhibitor | 0.045 0.026 CID_5288478 | CID_5288478 | |
| 0.004 | 0.986 | 0.04 | Cholecystokinin B agonist | 0.04 0.023 CID_5288478 | CID_5288478 | |
| 0.003 | 0.987 | 0.051 | Erythropoietin receptor agonist | 0.051 0.021 CID_5288478 | CID_5288478 | |
| 0.002 | 0.987 | 0.102 | Glucagon-like peptide 1 agonist | 0.102 0.021 CID_5288478 | CID_5288478 | |
| 0.001 | 0.99 | 0.048 | Complement C3a chemotactic receptor antagonist | 0.048 0.028 CID_5288478 | CID_5288478 | |
| 0.001 | 0.991 | 0.029 | Bradykinin B2 receptor agonist | 0.029 0.019 CID_5288478 | CID_5288478 | |
| 0.002 | 0.995 | 0.026 | Protocollagen prolyl hydroxylase inhibitor | 0.026 0.022 CID_5288478 | CID_5288478 | |
| 0.001 | 0.996 | 0.059 | Prostaglandin EP2 antagonist | 0.059 0.042 CID_5288478 | CID_5288478 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |